Cargando…
Parkinsonism as a Third Wave of the COVID-19 Pandemic?
Since the initial reports of COVID-19 in December 2019, the world has been gripped by the disastrous acute respiratory disease caused by the SARS-CoV-2 virus. There are an ever-increasing number of reports of neurological symptoms in patients, from severe (encephalitis), to mild (hyposmia), suggesti...
Autores principales: | Beauchamp, Leah C., Finkelstein, David I., Bush, Ashley I., Evans, Andrew H., Barnham, Kevin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683045/ https://www.ncbi.nlm.nih.gov/pubmed/32986683 http://dx.doi.org/10.3233/JPD-202211 |
Ejemplares similares
-
Reduced striatal vesicular monoamine transporter 2 in REM sleep behavior disorder: imaging prodromal parkinsonism
por: Beauchamp, Leah C., et al.
Publicado: (2020) -
ATH434 Rescues Pre-motor Hyposmia in a Mouse Model of Parkinsonism
por: Beauchamp, Leah C., et al.
Publicado: (2022) -
Ablation of tau causes an olfactory deficit in a murine model of Parkinson’s disease
por: Beauchamp, Leah C., et al.
Publicado: (2018) -
Transferrin protects against Parkinsonian neurotoxicity and is deficient in Parkinson’s substantia nigra
por: Ayton, Scott, et al.
Publicado: (2016) -
Iron accumulation confers neurotoxicity to a vulnerable population of nigral neurons: implications for Parkinson’s disease
por: Ayton, Scott, et al.
Publicado: (2014)